Introduction
This syllabus provides a comprehensive overview of upright digital breast tomosynthesis (DBT)–guided breast biopsy, including rationale, equipment, workflow, targeting and biopsy technique, evidence base, lesion-specific considerations, quality assurance, and radiologic–pathologic correlation. Case-based pearls illustrate real-world decision-making for architectural distortion, masses, and calcifications, including management of discordant pathology and high-risk entities.
Rationale for Tomosynthesis-Guided Breast Biopsy
DBT increases cancer detection, particularly for subtle architectural distortion that may be occult on conventional 2D mammography. When sonographic correlation is absent or uncertain and 2D stereotactic targeting is limited, DBT-guided biopsy provides precise, efficient, and comfortable lesion sampling in the upright position.
Key Points
- DBT depicts architectural distortion and subtle noncalcified lesions better than 2D mammography.
- Absent/uncertain sonographic correlates and equivocal 2D stereotactic localization are prime indications for DBT-guided biopsy.
- Upright workflow improves patient comfort and reduces procedure time and radiation dose compared with prone 2D stereotactic biopsy.
Limitations of Ultrasound and 2D Stereotactic Biopsy
Ultrasound may fail to demonstrate DBT-only distortions or masses; patient positioning can displace lesions, risking incorrect targeting. 2D stereotactic localization relies on angled views of poorly visualized findings, complicating depth calculation and prolonging procedures.
Key Points
- Position changes from mammography to ultrasound can misregister lesion location (e.g., superior tissue falling laterally supine).
- 2D stereotactic targeting of architectural distortion is challenging when the correlate is not well seen on either angled view.
- Stereotactic tables can be uncomfortable and time-consuming compared with upright DBT biopsy.
Equipment and Room Setup
Modern DBT systems accept biopsy attachments (e.g., Hologic Affirm) that enable motorized targeting and upright sampling using a vacuum-assisted device and standard biopsy needles. Console interfaces support slice scrolling, coordinate selection, and real-time feasibility checks.
Key Points
- Attachment features: motorized needle guidance, on-unit display, detachable design for rapid conversion between diagnostic and biopsy modes.
- Patient seating: adjustable upright chair; capacity to recline if vasovagal symptoms occur.
- Biopsy system: vacuum-assisted device compatible with upright use; specimen radiography (e.g., Faxitron) for calcification confirmation.
- Targeting console: DBT slice selection within an open biopsy window; automatic thickness and detector clearance assessment.
Target Selection and DBT Localization
Targeting is performed by scrolling to the slice where the lesion is best visualized and selecting the precise target point within the biopsy window. The system validates breast thickness, anticipated needle trajectory, and detector clearance, with safety margins and adjustable coordinates.
Key Points
- Verify the target lies within the open biopsy window; select the slice with maximal conspicuity.
- Automated checks include breast thickness, needle fit, and minimum detector “dead space” (~3 mm) clearance.
- Coordinate adjustments can reposition along the device trough (standard ~20 mm; petite ~12 mm) to access posterior targets.
- Review vascular anatomy on DBT to avoid intraprocedural bleeding.
Biopsy Technique and Workflow
After sterile prep and local anesthesia, the needle is advanced (“dialed”) to a pre-fire position, verified on a pre-fire DBT or stereotactic image. A controlled “fire” advances the needle (e.g., ~23 mm) to minimize tissue tenting, followed by vacuum-assisted sampling, clip deployment, and post-procedure mammography.
Key Points
- Pre-fire verification ensures accurate approach relative to the target; retarget on the same DBT image if needed.
- The final “fire” provides rapid insertion into target tissue, reducing tissue displacement and needle bending.
- Specimen radiography: useful for calcifications; not helpful for noncalcified targets (may otherwise prompt extra cores).
- Place a marker clip and obtain post-biopsy mammograms to document location and assess for clip migration or hematoma.
Evidence Base and Performance Metrics
Multiple studies demonstrate high technical success, faster procedure times, and favorable patient tolerance for DBT-guided biopsy versus 2D stereotactic prone biopsy. Institutional experience corroborates comparable accuracy with expanded capability for noncalcified targets.
Key Points
- Schrading et al., 2015: 100% DBT targeting success vs 93% with 2D; mean time 13 minutes (DBT) vs 29 minutes (2D); 1/51 vasovagal reaction; superior for noncalcified lesions.
- Breast Journal, 2013: 118 biopsies of distortions, masses, and calcifications with high success.
- 2018 series: DBT-only lesions and DBT-only distortion showed high malignancy rates.
- Institutional cohort (n>200): similar targeting success and PPV between Affirm and prone stereotactic; tissue migration similar; slightly higher hematoma rates and cores with Affirm (likely due to lack of specimen confirmation for noncalcified targets).
Indications and Lesion Types
DBT-guided biopsy is appropriate for calcified and noncalcified targets, including architectural distortion, DBT-only masses, and subtle lesions not confidently localized on ultrasound or 2D.
Key Points
- Architectural distortion: common DBT indication; includes noncalcified DCIS and invasive lobular carcinoma (ILC).
- Masses: DBT-only masses without US correlate are well-suited for DBT-guided sampling.
- Calcifications: can be targeted by DBT or 2D stereotactic; DBT enables single-image slice selection.
- Microcalcifications: assess morphology on magnification (e.g., fine pleomorphic, coarse heterogeneous); include a true lateral to assess layering (milk of calcium).
Quality Assurance and Troubleshooting
Robust pre-procedure checks and intra-procedural flexibility improve safety and outcomes. Equipment function, vascular mapping, and the ability to retarget on pre-fire images are central to quality.
Key Points
- Pre-test device firing; ensure the probe is loaded and fires completely to maintain vacuum suction.
- If pre-fire images show misalignment, retarget directly on the pre-fire tomo and motor-adjust to the new coordinates.
- Manage vasovagal reactions by reclining; monitor for hematoma formation.
- Take additional cores judiciously when specimen radiography cannot confirm target capture (noncalcified lesions).
Radiologic–Pathologic Correlation and Management
Concordance assessment is required for all breast biopsies. Discordant benign findings after targeting a suspicious lesion warrant escalation, often with surgical excision and image-guided localization.
Key Points
- Concordant examples: fibroadenoma explaining coarse heterogeneous calcifications; cyst wall for a targeted mass.
- Discordant benign (e.g., benign breast tissue after sampling a defined mass) requires re-biopsy or surgical excision.
- Localization methods (e.g., SAVI/Savi Scout) facilitate accurate surgical targeting of marker clips.
- Complex sclerosing lesions (radial scar ≤1 cm) are high-risk; surgical excision is typically recommended due to upstage risk (higher with older age, larger size, associated atypia).
Case 1: DBT-Only Architectural Distortion → ILC
A 76-year-old on anticoagulation with DBT-detected architectural distortion without sonographic correlate underwent DBT-guided biopsy; pathology: invasive lobular carcinoma (ILC). Specimen radiograph did not aid because the target was noncalcified.
Key Points
- ILC may present as subtle architectural distortion without calcifications; DBT improves detection.
- Specimen radiography is generally not helpful for noncalcified targets.
- Expect mild distortion with minimal desmoplasia on 2D; prioritize DBT for targeting.
Case 2: New Microcalcifications → Fibroadenoma
A 57-year-old with new central calcifications underwent magnification and lateral views; morphology favored coarse heterogeneous calcifications. DBT-guided biopsy confirmed calcifications on specimen radiography; pathology: fibroadenoma with concordant associated calcifications.
Key Points
- Always obtain magnification and true lateral views for microcalcifications; assess for milk of calcium.
- Coarse heterogeneous calcifications can be associated with fibroadenoma.
- DBT targeting uses single-slice selection; specimen radiography confirms calcification retrieval.
Case 3: DBT-Only Mass, Device Issue → Discordance and Excision
A 75-year-old with a DBT-only mass had poor vacuum suction due to incomplete device firing, yielding benign breast tissue without explanation (discordant). Surgical localization and excision revealed benign entities (fibroadenomatoid change, sclerosing adenosis, cysts) concordant with a mass.
Key Points
- Always verify device firing and vacuum function pre-procedure.
- Discordant benign results after a targeted mass require excision.
- Document clip location; use localization devices to guide surgery.
Case 4: Architectural Distortion with Mass → Noncalcified DCIS
A 62-year-old with upper outer quadrant distortion and enhancing mass on MRI underwent DBT-guided biopsy. Real-time retargeting on pre-fire tomo improved accuracy. Pathology: high-grade DCIS without calcifications.
Key Points
- DBT allows immediate retargeting on pre-fire images for precise sampling.
- A subset of DCIS is noncalcified and may present as distortion or mass.
- Post-biopsy views can appear obliqued due to vessel avoidance; rely on standard post-procedure views for clip assessment.
Case 5: Multiple Architectural Distortions → DCIS and Complex Sclerosing Lesion
A post-mastectomy patient had two areas of architectural distortion; DBT enabled targeting both in one session. Specimen radiography confirmed associated calcifications in one target. Pathology: DCIS at one site; complex sclerosing lesion at the other.
Key Points
- DBT facilitates efficient multi-target biopsies; sample the most suspicious lesion first.
- Complex sclerosing lesions are high risk and often excised due to upstage potential.
- Monitor for clip migration; correlate on orthogonal views.
Practical Pearls for Daily Practice
DBT-guided biopsy streamlines targeting, reduces procedure times, and broadens access to noncalcified lesions. Thoughtful workflow and QA enhance safety and diagnostic yield.
Key Points
- Verify detector clearance and breast thickness before transmitting coordinates.
- Use vessel mapping on DBT to avoid vascular injury; expect slightly higher hematoma rates when taking more cores.
- For noncalcified targets, limit reliance on specimen radiography; instead, ensure accurate targeting and adequate sampling.
- Maintain rigorous radiologic–pathologic correlation and clear communication for discordant management.
Conclusion
Upright DBT-guided breast biopsy delivers high technical success, improved patient comfort, reduced time and dose, and reliable targeting of calcified and noncalcified lesions, particularly architectural distortion and DBT-only masses. Mastery of equipment, targeting mechanics, and QA processes—combined with disciplined radiologic–pathologic correlation—optimizes diagnostic performance and patient outcomes. Institutions can confidently adopt DBT-guided biopsy as a primary approach for mammographic targets, reserving ultrasound guidance when a confident correlate exists.
